Transfusion independence and survival in patients with acute myeloid leukemia treated with 5-azacytidine

被引：24
|
作者：
Gavillet, Mathilde [1 ]
Noetzli, Jasmine [1 ]
Blum, Sabine [1 ]
Duchosal, Michel A. [1 ]
Spertini, Olivier [1 ]
Lambert, Jean-Francois [1 ]
机构：
[1] Univ Lausanne Hosp, Serv & Cent Lab Hematol, CH-1011 Lausanne, Switzerland
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2012年 / 97卷 / 12期
关键词：
5-azacytidine; acute myeloid leukemia; transfusion independence; survival; CONVENTIONAL CARE REGIMENS; LOW-DOSE CYTARABINE; MYELODYSPLASTIC SYNDROMES; AZACITIDINE; TRIALS;
D O I：
10.3324/haematol.2012.065151
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1929 / 1931
页数：3
相关论文
共 50 条
  • [1] TRANSFUSION INDEPENDENCE AND SURVIVAL IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH 5-AZACYTIDINE
    Gavillet, M.
    Noetzli, J.
    Blum, S.
    Spertini, O.
    Duchosal, M.
    Lambert, J. F.
    HAEMATOLOGICA, 2012, 97 : 268 - 269
  • [2] Maintenance with 5-Azacytidine for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients
    Oran, Betul
    de Lima, Marcos
    Garcia-Manero, Guillermo
    Thall, Peter F.
    Lin, Ruitao
    Alousi, Amin M.
    Hosing, Chitra
    Kebriaei, Partow
    Popat, Uday
    Giralt, Sergio
    Ahmed, Sairah
    Shpall, Elizabeth J.
    Andersson, Borje S.
    Bashir, Qaiser
    Ciurea, Stefan O.
    Rezvani, Katy
    Woodworth, Glenda
    Champlin, Richard E.
    BLOOD, 2018, 132
  • [3] Immunomodulatory effects of 5-azacytidine in acute myeloid leukemia
    Letsch, Anne
    Doering, Susanne
    Quass, Petra
    Pezzutto, Antonio
    Ochsenreither, Sebastian
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Risk factors for invasive fungal infection in 5-azacytidine treated patients with acute myeloid leukemia and myelodysplastic syndrome
    Tey, Amanda
    Shaw, Briony
    Cardamone, Luke
    Shepherd, Sam
    Paul, Eldho
    Rogers, Ben
    Shortt, Jake
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (02) : 181 - 189
  • [5] Post-Myelofibrosis Acute Myeloid Leukemia Effectively Treated with a Combination of Ruxolitinib and 5-Azacytidine
    Diamantopoulos, Panagiotis T.
    Giannakopoulou, Nefeli
    Hatzidavid, Sevastianos
    Viniou, Nora-Athina
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (10) : 532 - 535
  • [6] Impact of karyotype and mutations on the survival of acute myeloblastic leukemia in elderly patients treated with 5-azacytidine or conventional therapy
    Eclache, Virginie
    HEMATOLOGIE, 2019, 25 (01): : 7 - 8
  • [7] 5-AZACYTIDINE IN ACUTE-LEUKEMIA
    SAIKI, JH
    MCCREDIE, K
    VIETTI, T
    HEWLETT, J
    MORRISON, F
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 339 - 339
  • [8] TREATMENT OF ACUTE LEUKEMIA WITH 5-AZACYTIDINE
    MCCREDIE, KB
    FREIREIC.EJ
    RODRIGUE.V
    SULLIVAN, MP
    BURGESS, MA
    BODEY, GP
    BLOOD-THE JOURNAL OF HEMATOLOGY, 1972, 40 (06): : 975 - &
  • [9] 5-AZACYTIDINE IN ACUTE-LEUKEMIA
    SAIKI, JH
    MCCREDIE, KB
    VIETTI, TJ
    HEWLETT, JS
    MORRISON, FS
    COSTANZI, JJ
    STUCKEY, WJ
    WHITECAR, J
    HOOGSTRATEN, B
    CANCER, 1978, 42 (05) : 2111 - 2114
  • [10] Characterization of the T-Cell receptor repertoire in patients with acute myeloid leukemia treated with 5-Azacytidine plus chemotherapy
    Beckford, John
    Fulton, Noreen
    Odenike, Toyosi
    Stock, Wendy
    Alachkar, Houda
    CANCER RESEARCH, 2020, 80 (16)
12345